Entering text into the input field will update the search result below
Create free account
Search for Symbols, analysts, keywords
Log in
News
Trending News
AI Tech
All News
Biotech
Buybacks
Commodities
Consumer
Cryptocurrency
Debt/Share Issuance
Dividends - Funds
Dividends - Stocks
Earnings
Energy
Financials
Global Macro
Graphical News
Guidance
Healthcare
Interest Rates
IPOs
M&A
Magnificent 7
Market Pulse
MLPs
Notable Calls
On The Move
Politics
REITs
SPACs
Tech
Top News
U.S Economy
Weight Loss
Show Full Stories
Novo Nordisk, J&J lead R&D rankings in big pharma: report
Boston Scientific succeeds in pivotal trial for leadless pacemaker
HCA among beneficiaries of latest healthcare related hack: Jefferies
Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO
Achilles Therapeutics receives non-compliance notice from Nasdaq
Fortress Biotech files for $50M mixed shelf
Medtronic study of Affera Sphere-9 Catheter meets endpoints
Phio Pharmaceuticals files for $100M mixed securities shelf
DBV Technologies to implement ADS ratio change
Jaguar Health announces 1-for-60 reverse stock split
Virios Therapeutics announces proposed public offering of common stock
Medtronic stock trades up for the seventh straight session
Telix, Australian radiopharmaceuticals maker, files for $100M US IPO
Puma Biotech pares gain amid Wyeth victory in Tagrisso patent case against AstraZeneca
iRhythm stock falls as much as 8% amid Zio media report
Regeneron wins temporary restraining order preventing Eylea generic launch (update)
Moderna vaccine patent upheld by European Patent Office: report
Federal Reserve Chair Jerome Powell tests positive for Covid-19
Senzime appoints Wolfgang Reim as new senior advisor to the board
Cytokinetics CEO Blum says positioned to market heart drug aficamten by itself
Akanda announces registered direct offering priced ATM
Heart Test conducts 1-for-100 reverse stock split
DoJ proposed cannabis rescheduling rule says DEA still hasn't weighed in
Erasca stock climbs 10% amid pipeline restructuring, equity offering
Capricor Therapeutics stock rises, Oppenheimer initiates coverage at Outperform
1
2
3
4
5
Next
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.